CAPhO Educational Webinar Series - CAR-T Therapy: Updates and Implications for Oncology Pharmacy now available online
The webinar CAR-T Therapy: Updates and Implications for Oncology Pharmacy presented by Melanie Trinacty, BSc, BScPharm, ACPR from The Ottawa Hospital, is now available online.
Chimeric Antigen Receptor T-cell therapy has been described as "ground-breaking" therapy with huge potential for treatment of many cancer types. Join your CAPhO colleagues from across the country for an overview of what the oncology/hematology pharmacist needs to know about this exciting new therapy!
In one hour, Melanie will:
- Describe the mechanism and components of CAR T-cell therapy
- Review which products are available in Canada and the evidence for each indication
- Identify eligible patients for CAR T-cell therapy
- Describe and review management of the common toxicities associated with CAR T-cell therapy